RxDoctor Payments Data

Patsy Buccino, DO

Family Medicine · Girard, OHNPI 1982673232

Payments from drug & device makers

$2,053in general payments, 2019–2025

Across 117 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$288
  • Pfizer$221
  • AbbVie$211
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$194
  • Biohaven Pharmaceuticals, Inc.$149
  • Corcept Therapeutics$123
  • plus $867 from 22 others

What the payments were for

  • Food & beverage$2,053100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,053 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$100,674
Medicare patients
248
Services billed
1,303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban275$250,925
OzempicSemaglutide99$127,575
JardianceEmpagliflozin67$86,227
EntrestoSacubitril/Valsartan44$56,038
MounjaroTirzepatide45$48,430
TradjentaLinagliptin49$34,974
TrulicityDulaglutide25$28,365
MyrbetriqMirabegron21$17,030
XareltoRivaroxaban24$14,212
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$13,568
CreonLipase/Protease/Amylase18$6,909
Janumet XrSitagliptin Phos/Metformin Hcl14$6,856
Levemir FlexpenInsulin Detemir11$6,686
Atorvastatin Calcium704$6,140
DexilantDexlansoprazole15$5,571

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$221$250,925275 claims
Novo NordiskOzempic$14$127,57599 claims
Boehringer IngelheimJardiance, Tradjenta$32$121,201116 claims
Lilly USA, LLCMounjaro, Trulicity$120$76,79570 claims
NovartisEntresto$23$56,03844 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy$14$22,63947 claims
Astellas Pharma US IncMyrbetriq$13$17,03021 claims
Johnson & JohnsonXarelto$25$14,21224 claims
AbbVieCreon, Synthroid$211$11,119104 claims
MerckJanumet Xr$33$6,85614 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant$28$5,57115 claims
AstraZenecaSymbicort$288$4,89320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Girard

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →